Cargando…
Durable control of metastases in an HLA-A2+ patient with refractory melanoma after low-dose radiotherapy in combination with MAGE-A4 T cell therapy: a case report
There is no currently approved adoptive cellular therapy for solid tumors. Pre-clinical and clinical studies have demonstrated that low-dose radiotherapy (LDRT) can enhance intratumoral T cell infiltration and efficacy. This case report describes a 71-year-old female patient with rectal mucosal mela...
Autores principales: | He, Kewen, Hong, David S., Ke, Danxia, Kebriaei, Partow, Wang, Tianjiao, Danesi, Hassan, Bertolet, Genevieve, Leuschner, Carola, Puebla-Osorio, Nahum, Voss, Tiffany A., Lin, Quan, Norry, Elliot, Fracasso, Paula M., Welsh, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309102/ https://www.ncbi.nlm.nih.gov/pubmed/37325860 http://dx.doi.org/10.1097/CMR.0000000000000869 |
Ejemplares similares
-
Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases
por: He, Kewen, et al.
Publicado: (2021) -
Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab
por: Kim, Sang T., et al.
Publicado: (2021) -
Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection
por: Hu, Yun, et al.
Publicado: (2023) -
Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
por: Hu, Yun, et al.
Publicado: (2022) -
Autologous T cell therapy for MAGE-A4(+) solid cancers in HLA-A*02(+) patients: a phase 1 trial
por: Hong, David S., et al.
Publicado: (2023)